Is Mounjaro still on shortage?

FDA officially declared the tirzepatide shortage RESOLVED in October 2024. This triggered the 503A compounding wind-down — compounded tirzepatide must cease within 60 days of FDA shortage resolution declaration. Regional supply intermittency persists at some doses (5mg, 7.5mg are most common gaps). If your pharmacy is out, check: another local pharmacy, LillyDirect cash-pay ($549/month maintenance), telehealth compounders before their wind-down deadline. Brand Mounjaro is the most reliable supply path post-shortage.

Does Blue Cross Blue Shield cover Mounjaro? Coverage, PA, and cash-pay (2026)

About Blue Cross Blue Shield

How Blue Cross Blue Shield handles GLP-1s

BCBS is a federation of 33 independent regional plans. Coverage varies by state plan, but most regional BCBS follow similar formulary patterns for GLP-1s.

Prior authorization

What Blue Cross Blue Shield requires for Mounjaro

T2D diagnosis + metformin trial. A1C ≥ 7.0 typical.

When coverage fails

Cash-pay route

Savings card to $25/mo.

Editorial notes

Step therapy from Ozempic common in some BCBS state plans.

Other drugs on Blue Cross Blue Shield

Blue Cross Blue Shield Wegovy →
Blue Cross Blue Shield Zepbound →
Blue Cross Blue Shield Ozempic →
Blue Cross Blue Shield Saxenda →

Mounjaro on other insurers

Aetna Mounjaro →
Cigna Mounjaro →
UnitedHealthcare Mounjaro →
Humana Mounjaro →
Kaiser Permanente Mounjaro →
Anthem Mounjaro →

Editorial summary, not legal or medical advice. Insurance formularies change quarterly. Verify with your specific plan member services before relying on any single source. Copay ranges reflect typical commercial plans; your plan may differ.